Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Addus HomeCare Corporation (NASDAQ:ADUS) has received an average recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $131.00.

ADUS has been the subject of several recent research reports. Barclays lowered their price objective on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a research report on Friday, May 15th. Citizens Jmp restated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Finally, Weiss Ratings lowered shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd.

Addus HomeCare Price Performance

ADUS opened at $105.17 on Friday. Addus HomeCare has a 12 month low of $87.95 and a 12 month high of $124.43. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The business’s 50-day moving average price is $95.10 and its 200-day moving average price is $101.31. The company has a market cap of $1.96 billion, a P/E ratio of 19.44, a P/E/G ratio of 1.44 and a beta of 0.88.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The company had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. During the same period in the prior year, the business posted $1.42 EPS. Addus HomeCare’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, equities analysts expect that Addus HomeCare will post 6.24 EPS for the current year.

Insider Activity

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 966 shares of company stock valued at $90,168 in the last 90 days. 4.10% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

Large investors have recently modified their holdings of the business. Global Retirement Partners LLC grew its position in shares of Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares during the last quarter. Larson Financial Group LLC increased its stake in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares during the period. Acumen Wealth Advisors LLC bought a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $29,000. Private Trust Co. NA raised its holdings in shares of Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after acquiring an additional 112 shares in the last quarter. Finally, Arax Advisory Partners lifted its stake in Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after acquiring an additional 137 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.